nodes	percent_of_prediction	percent_of_DWPC	metapath
Oseltamivir—CES1—Capecitabine—esophageal cancer	0.584	0.788	CbGbCtD
Oseltamivir—ABCC4—Methotrexate—esophageal cancer	0.0969	0.131	CbGbCtD
Oseltamivir—SLC22A8—Methotrexate—esophageal cancer	0.0605	0.0817	CbGbCtD
Oseltamivir—CES1—larynx—esophageal cancer	0.0156	0.251	CbGeAlD
Oseltamivir—NEU1—bronchus—esophageal cancer	0.00691	0.111	CbGeAlD
Oseltamivir—NEU1—smooth muscle tissue—esophageal cancer	0.00676	0.109	CbGeAlD
Oseltamivir—NEU1—Sialic acid metabolism—ST6GAL1—esophageal cancer	0.00642	0.0525	CbGpPWpGaD
Oseltamivir—NEU1—trachea—esophageal cancer	0.0062	0.0996	CbGeAlD
Oseltamivir—NEU2—Sialic acid metabolism—ST6GAL1—esophageal cancer	0.00487	0.0398	CbGpPWpGaD
Oseltamivir—CES1—Irinotecan Pathway—ABCC2—esophageal cancer	0.0048	0.0392	CbGpPWpGaD
Oseltamivir—NEU1—Synthesis of substrates in N-glycan biosythesis—ST6GAL1—esophageal cancer	0.00446	0.0365	CbGpPWpGaD
Oseltamivir—NEU1—lung—esophageal cancer	0.00446	0.0716	CbGeAlD
Oseltamivir—CES1—neck—esophageal cancer	0.00415	0.0666	CbGeAlD
Oseltamivir—NEU1—Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein—ST6GAL1—esophageal cancer	0.00365	0.0298	CbGpPWpGaD
Oseltamivir—NEU2—Synthesis of substrates in N-glycan biosythesis—ST6GAL1—esophageal cancer	0.00338	0.0277	CbGpPWpGaD
Oseltamivir—CES1—Fluoropyrimidine Activity—XRCC3—esophageal cancer	0.00332	0.0272	CbGpPWpGaD
Oseltamivir—Immunodeficiency—Methotrexate—esophageal cancer	0.00307	0.0414	CcSEcCtD
Oseltamivir—NEU1—lymph node—esophageal cancer	0.00305	0.0489	CbGeAlD
Oseltamivir—Angina unstable—Capecitabine—esophageal cancer	0.00283	0.0381	CcSEcCtD
Oseltamivir—CES1—Fluoropyrimidine Activity—TYMP—esophageal cancer	0.00279	0.0228	CbGpPWpGaD
Oseltamivir—NEU2—Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein—ST6GAL1—esophageal cancer	0.00276	0.0226	CbGpPWpGaD
Oseltamivir—SLC15A1—epithelium—esophageal cancer	0.00262	0.042	CbGeAlD
Oseltamivir—ABCC4—Drug Induction of Bile Acid Pathway—NR1I2—esophageal cancer	0.00249	0.0203	CbGpPWpGaD
Oseltamivir—NEU1—Asparagine N-linked glycosylation—ST6GAL1—esophageal cancer	0.00232	0.0189	CbGpPWpGaD
Oseltamivir—ABCC4—Drug Induction of Bile Acid Pathway—ABCC2—esophageal cancer	0.00222	0.0181	CbGpPWpGaD
Oseltamivir—CES1—digestive system—esophageal cancer	0.00215	0.0345	CbGeAlD
Oseltamivir—SLC15A1—digestive system—esophageal cancer	0.00199	0.032	CbGeAlD
Oseltamivir—CES1—Fluoropyrimidine Activity—CYP2A6—esophageal cancer	0.00193	0.0158	CbGpPWpGaD
Oseltamivir—ABCC4—bronchus—esophageal cancer	0.00187	0.03	CbGeAlD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—XRCC3—esophageal cancer	0.00179	0.0147	CbGpPWpGaD
Oseltamivir—CES1—lung—esophageal cancer	0.00179	0.0288	CbGeAlD
Oseltamivir—NEU2—Asparagine N-linked glycosylation—ST6GAL1—esophageal cancer	0.00176	0.0144	CbGpPWpGaD
Oseltamivir—CES1—Fluoropyrimidine Activity—SMUG1—esophageal cancer	0.00157	0.0129	CbGpPWpGaD
Oseltamivir—CES1—NRF2 pathway—ALDH3A1—esophageal cancer	0.00157	0.0128	CbGpPWpGaD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—TYMP—esophageal cancer	0.0015	0.0123	CbGpPWpGaD
Oseltamivir—ABCC4—digestive system—esophageal cancer	0.00144	0.0232	CbGeAlD
Oseltamivir—CES1—NRF2 pathway—BLVRB—esophageal cancer	0.0014	0.0114	CbGpPWpGaD
Oseltamivir—NEU1—Asparagine N-linked glycosylation—CALR—esophageal cancer	0.0014	0.0114	CbGpPWpGaD
Oseltamivir—CES1—E2F transcription factor network—XRCC1—esophageal cancer	0.00128	0.0105	CbGpPWpGaD
Oseltamivir—Hepatotoxicity—Cisplatin—esophageal cancer	0.00126	0.0169	CcSEcCtD
Oseltamivir—CES1—lymph node—esophageal cancer	0.00123	0.0197	CbGeAlD
Oseltamivir—ABCC4—ABC-family proteins mediated transport—ABCC2—esophageal cancer	0.00122	0.00995	CbGpPWpGaD
Oseltamivir—ABCC4—lung—esophageal cancer	0.00121	0.0194	CbGeAlD
Oseltamivir—NEU1—Post-translational protein modification—ST6GAL1—esophageal cancer	0.0012	0.0098	CbGpPWpGaD
Oseltamivir—Rhinorrhoea—Cisplatin—esophageal cancer	0.0012	0.0161	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—PRDX1—esophageal cancer	0.00119	0.00973	CbGpPWpGaD
Oseltamivir—ABCC4—Drug Induction of Bile Acid Pathway—ABCB1—esophageal cancer	0.00118	0.00962	CbGpPWpGaD
Oseltamivir—Infection—Carboplatin—esophageal cancer	0.00117	0.0158	CcSEcCtD
Oseltamivir—Encephalopathy—Capecitabine—esophageal cancer	0.00111	0.015	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—SLC39A6—esophageal cancer	0.00106	0.00867	CbGpPWpGaD
Oseltamivir—NEU2—Asparagine N-linked glycosylation—CALR—esophageal cancer	0.00106	0.00866	CbGpPWpGaD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—CYP2A6—esophageal cancer	0.00104	0.00852	CbGpPWpGaD
Oseltamivir—CES1—NRF2 pathway—ADH7—esophageal cancer	0.00101	0.00827	CbGpPWpGaD
Oseltamivir—Pain—Carboplatin—esophageal cancer	0.00101	0.0136	CcSEcCtD
Oseltamivir—Throat sore—Capecitabine—esophageal cancer	0.000993	0.0134	CcSEcCtD
Oseltamivir—Oropharyngeal discomfort—Capecitabine—esophageal cancer	0.000984	0.0133	CcSEcCtD
Oseltamivir—Hepatocellular injury—Cisplatin—esophageal cancer	0.000971	0.0131	CcSEcCtD
Oseltamivir—Body temperature increased—Carboplatin—esophageal cancer	0.000933	0.0126	CcSEcCtD
Oseltamivir—Hepatotoxicity—Capecitabine—esophageal cancer	0.000927	0.0125	CcSEcCtD
Oseltamivir—Otitis media—Capecitabine—esophageal cancer	0.000919	0.0124	CcSEcCtD
Oseltamivir—NEU2—Post-translational protein modification—ST6GAL1—esophageal cancer	0.000909	0.00743	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000897	0.00733	CbGpPWpGaD
Oseltamivir—Rhinorrhoea—Capecitabine—esophageal cancer	0.000883	0.0119	CcSEcCtD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—SMUG1—esophageal cancer	0.000849	0.00694	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—ALDH3A1—esophageal cancer	0.000848	0.00693	CbGpPWpGaD
Oseltamivir—Encephalopathy—Methotrexate—esophageal cancer	0.00083	0.0112	CcSEcCtD
Oseltamivir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.000828	0.00677	CbGpPWpGaD
Oseltamivir—ABCC4—lymph node—esophageal cancer	0.000825	0.0132	CbGeAlD
Oseltamivir—Oropharyngeal pain—Capecitabine—esophageal cancer	0.000787	0.0106	CcSEcCtD
Oseltamivir—Liver disorder—Methotrexate—esophageal cancer	0.000781	0.0105	CcSEcCtD
Oseltamivir—Herpes simplex—Capecitabine—esophageal cancer	0.000776	0.0105	CcSEcCtD
Oseltamivir—Nasal congestion—Cisplatin—esophageal cancer	0.000773	0.0104	CcSEcCtD
Oseltamivir—ABCC4—Platelet degranulation—PFN1—esophageal cancer	0.000763	0.00624	CbGpPWpGaD
Oseltamivir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.000758	0.00619	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—BLVRB—esophageal cancer	0.000756	0.00618	CbGpPWpGaD
Oseltamivir—CES1—NRF2 pathway—ABCC2—esophageal cancer	0.000735	0.00601	CbGpPWpGaD
Oseltamivir—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.000728	0.00981	CcSEcCtD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—PFN1—esophageal cancer	0.000727	0.00594	CbGpPWpGaD
Oseltamivir—NEU1—Post-translational protein modification—CALR—esophageal cancer	0.000723	0.00591	CbGpPWpGaD
Oseltamivir—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.000705	0.00949	CcSEcCtD
Oseltamivir—Influenza like illness—Capecitabine—esophageal cancer	0.000695	0.00936	CcSEcCtD
Oseltamivir—Hepatotoxicity—Methotrexate—esophageal cancer	0.00069	0.00929	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—NFE2L2—esophageal cancer	0.000683	0.00559	CbGpPWpGaD
Oseltamivir—Face oedema—Cisplatin—esophageal cancer	0.00068	0.00916	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.00068	0.00556	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—XBP1—esophageal cancer	0.000659	0.00539	CbGpPWpGaD
Oseltamivir—ABCC4—ABC-family proteins mediated transport—ABCB1—esophageal cancer	0.000646	0.00528	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—PRDX1—esophageal cancer	0.000642	0.00525	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—SLC30A7—esophageal cancer	0.000632	0.00517	CbGpPWpGaD
Oseltamivir—Nasopharyngitis—Cisplatin—esophageal cancer	0.00063	0.00849	CcSEcCtD
Oseltamivir—ABCC4—Platelet degranulation—CFL1—esophageal cancer	0.000618	0.00505	CbGpPWpGaD
Oseltamivir—Ear pain—Capecitabine—esophageal cancer	0.000609	0.0082	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000606	0.00495	CbGpPWpGaD
Oseltamivir—Diabetes mellitus—Capecitabine—esophageal cancer	0.000597	0.00804	CcSEcCtD
Oseltamivir—Hepatic function abnormal—Capecitabine—esophageal cancer	0.000594	0.008	CcSEcCtD
Oseltamivir—Bone disorder—Methotrexate—esophageal cancer	0.00059	0.00794	CcSEcCtD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—CFL1—esophageal cancer	0.000589	0.00481	CbGpPWpGaD
Oseltamivir—Swelling—Capecitabine—esophageal cancer	0.000589	0.00793	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—CYP2A6—esophageal cancer	0.000588	0.0048	CbGpPWpGaD
Oseltamivir—Herpes simplex—Methotrexate—esophageal cancer	0.000578	0.00778	CcSEcCtD
Oseltamivir—Hepatic failure—Capecitabine—esophageal cancer	0.000578	0.00778	CcSEcCtD
Oseltamivir—Eye pain—Capecitabine—esophageal cancer	0.000575	0.00775	CcSEcCtD
Oseltamivir—ABCC4—NRF2 pathway—SLC39A6—esophageal cancer	0.000573	0.00468	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—ST6GAL1—esophageal cancer	0.000569	0.00465	CbGpPWpGaD
Oseltamivir—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.000563	0.00758	CcSEcCtD
Oseltamivir—NEU2—Post-translational protein modification—CALR—esophageal cancer	0.000548	0.00448	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—ADH7—esophageal cancer	0.000546	0.00447	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000529	0.00432	CbGpPWpGaD
Oseltamivir—Conjunctivitis—Cisplatin—esophageal cancer	0.000528	0.00711	CcSEcCtD
Oseltamivir—Pain in extremity—Capecitabine—esophageal cancer	0.000519	0.007	CcSEcCtD
Oseltamivir—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.000519	0.007	CcSEcCtD
Oseltamivir—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000513	0.00692	CcSEcCtD
Oseltamivir—Face oedema—Capecitabine—esophageal cancer	0.000501	0.00675	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—XBP1—esophageal cancer	0.0005	0.00408	CbGpPWpGaD
Oseltamivir—Liver function test abnormal—Capecitabine—esophageal cancer	0.000479	0.00646	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—SLC30A7—esophageal cancer	0.000479	0.00392	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet degranulation—HSPA5—esophageal cancer	0.000475	0.00388	CbGpPWpGaD
Oseltamivir—Abdominal pain upper—Capecitabine—esophageal cancer	0.000474	0.00639	CcSEcCtD
Oseltamivir—NEU1—Metabolism—BLVRB—esophageal cancer	0.00047	0.00384	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—SLC52A3—esophageal cancer	0.00047	0.00384	CbGpPWpGaD
Oseltamivir—Visual impairment—Cisplatin—esophageal cancer	0.00047	0.00633	CcSEcCtD
Oseltamivir—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000468	0.0063	CcSEcCtD
Oseltamivir—Nasopharyngitis—Capecitabine—esophageal cancer	0.000464	0.00626	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000459	0.00375	CbGpPWpGaD
Oseltamivir—Eye disorder—Cisplatin—esophageal cancer	0.000455	0.00614	CcSEcCtD
Oseltamivir—CES1—E2F transcription factor network—CREBBP—esophageal cancer	0.000454	0.00371	CbGpPWpGaD
Oseltamivir—Lymphadenopathy—Methotrexate—esophageal cancer	0.000453	0.0061	CcSEcCtD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—HSPA5—esophageal cancer	0.000453	0.0037	CbGpPWpGaD
Oseltamivir—Cardiac disorder—Cisplatin—esophageal cancer	0.000452	0.00609	CcSEcCtD
Oseltamivir—CES1—E2F transcription factor network—RB1—esophageal cancer	0.000452	0.0037	CbGpPWpGaD
Oseltamivir—Influenza—Capecitabine—esophageal cancer	0.000449	0.00605	CcSEcCtD
Oseltamivir—Asthma—Capecitabine—esophageal cancer	0.000449	0.00605	CcSEcCtD
Oseltamivir—Diabetes mellitus—Methotrexate—esophageal cancer	0.000444	0.00599	CcSEcCtD
Oseltamivir—Immune system disorder—Cisplatin—esophageal cancer	0.00044	0.00593	CcSEcCtD
Oseltamivir—Mediastinal disorder—Cisplatin—esophageal cancer	0.000439	0.00592	CcSEcCtD
Oseltamivir—Angina pectoris—Capecitabine—esophageal cancer	0.000437	0.00589	CcSEcCtD
Oseltamivir—Arrhythmia—Cisplatin—esophageal cancer	0.000435	0.00586	CcSEcCtD
Oseltamivir—Bronchitis—Capecitabine—esophageal cancer	0.000432	0.00581	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—ST6GAL1—esophageal cancer	0.000431	0.00353	CbGpPWpGaD
Oseltamivir—Hepatic failure—Methotrexate—esophageal cancer	0.00043	0.00579	CcSEcCtD
Oseltamivir—SLC15A1—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000423	0.00346	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.00042	0.00343	CbGpPWpGaD
Oseltamivir—CES1—Fluoropyrimidine Activity—TP53—esophageal cancer	0.000417	0.00341	CbGpPWpGaD
Oseltamivir—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000417	0.00562	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—TGFBR2—esophageal cancer	0.000412	0.00337	CbGpPWpGaD
Oseltamivir—Visual disturbance—Methotrexate—esophageal cancer	0.000408	0.0055	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—HMOX1—esophageal cancer	0.000406	0.00332	CbGpPWpGaD
Oseltamivir—Pneumonia—Capecitabine—esophageal cancer	0.000403	0.00542	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000401	0.00328	CbGpPWpGaD
Oseltamivir—Infestation—Capecitabine—esophageal cancer	0.0004	0.00539	CcSEcCtD
Oseltamivir—Infestation NOS—Capecitabine—esophageal cancer	0.0004	0.00539	CcSEcCtD
Oseltamivir—NEU1—Metabolism—CA1—esophageal cancer	0.0004	0.00327	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—SLC10A2—esophageal cancer	0.0004	0.00327	CbGpPWpGaD
Oseltamivir—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000399	0.00538	CcSEcCtD
Oseltamivir—CES1—E2F transcription factor network—CDKN2A—esophageal cancer	0.000397	0.00325	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—ABCC2—esophageal cancer	0.000397	0.00324	CbGpPWpGaD
Oseltamivir—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000397	0.00534	CcSEcCtD
Oseltamivir—Anaemia—Cisplatin—esophageal cancer	0.000392	0.00528	CcSEcCtD
Oseltamivir—NEU1—Metabolism of proteins—ACTB—esophageal cancer	0.000392	0.0032	CbGpPWpGaD
Oseltamivir—Jaundice—Capecitabine—esophageal cancer	0.00039	0.00525	CcSEcCtD
Oseltamivir—Conjunctivitis—Capecitabine—esophageal cancer	0.000389	0.00524	CcSEcCtD
Oseltamivir—SLC15A1—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000387	0.00316	CbGpPWpGaD
Oseltamivir—ABCC4—Ectoderm Differentiation—SOX2—esophageal cancer	0.000386	0.00316	CbGpPWpGaD
Oseltamivir—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000379	0.0051	CcSEcCtD
Oseltamivir—Epistaxis—Capecitabine—esophageal cancer	0.000377	0.00508	CcSEcCtD
Oseltamivir—SLC22A8—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000376	0.00308	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—NFE2L2—esophageal cancer	0.000369	0.00302	CbGpPWpGaD
Oseltamivir—Convulsion—Cisplatin—esophageal cancer	0.000368	0.00495	CcSEcCtD
Oseltamivir—NEU1—Metabolism—CA2—esophageal cancer	0.000365	0.00299	CbGpPWpGaD
Oseltamivir—Myalgia—Cisplatin—esophageal cancer	0.000361	0.00487	CcSEcCtD
Oseltamivir—Anxiety—Cisplatin—esophageal cancer	0.00036	0.00485	CcSEcCtD
Oseltamivir—Hepatitis—Capecitabine—esophageal cancer	0.000359	0.00484	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000359	0.00483	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000357	0.00292	CbGpPWpGaD
Oseltamivir—Liver function test abnormal—Methotrexate—esophageal cancer	0.000357	0.00481	CcSEcCtD
Oseltamivir—NEU2—Metabolism—SLC52A3—esophageal cancer	0.000356	0.00291	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—BLVRB—esophageal cancer	0.000356	0.00291	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—HSPA5—esophageal cancer	0.000354	0.0029	CbGpPWpGaD
Oseltamivir—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000348	0.00469	CcSEcCtD
Oseltamivir—Anaphylactic shock—Cisplatin—esophageal cancer	0.000346	0.00466	CcSEcCtD
Oseltamivir—Visual impairment—Capecitabine—esophageal cancer	0.000346	0.00466	CcSEcCtD
Oseltamivir—SLC22A8—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000344	0.00281	CbGpPWpGaD
Oseltamivir—Infection—Cisplatin—esophageal cancer	0.000344	0.00463	CcSEcCtD
Oseltamivir—NEU1—Metabolism of proteins—CALR—esophageal cancer	0.000343	0.00281	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PLCE1—esophageal cancer	0.00034	0.00278	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—ADH7—esophageal cancer	0.00034	0.00278	CbGpPWpGaD
Oseltamivir—Erythema multiforme—Capecitabine—esophageal cancer	0.00034	0.00458	CcSEcCtD
Oseltamivir—Nervous system disorder—Cisplatin—esophageal cancer	0.00034	0.00457	CcSEcCtD
Oseltamivir—Thrombocytopenia—Cisplatin—esophageal cancer	0.000339	0.00457	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PFN1—esophageal cancer	0.000338	0.00277	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—GHRL—esophageal cancer	0.000337	0.00276	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—CAPZA1—esophageal cancer	0.000337	0.00276	CbGpPWpGaD
Oseltamivir—Skin disorder—Cisplatin—esophageal cancer	0.000336	0.00453	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000336	0.00275	CbGpPWpGaD
Oseltamivir—Eye disorder—Capecitabine—esophageal cancer	0.000336	0.00452	CcSEcCtD
Oseltamivir—Asthma—Methotrexate—esophageal cancer	0.000334	0.0045	CcSEcCtD
Oseltamivir—Cardiac disorder—Capecitabine—esophageal cancer	0.000333	0.00449	CcSEcCtD
Oseltamivir—NEU1—Metabolism of proteins—FBXW7—esophageal cancer	0.000332	0.00271	CbGpPWpGaD
Oseltamivir—CES1—E2F transcription factor network—CDKN1A—esophageal cancer	0.000325	0.00266	CbGpPWpGaD
Oseltamivir—Immune system disorder—Capecitabine—esophageal cancer	0.000325	0.00437	CcSEcCtD
Oseltamivir—Mediastinal disorder—Capecitabine—esophageal cancer	0.000324	0.00436	CcSEcCtD
Oseltamivir—Arrhythmia—Capecitabine—esophageal cancer	0.000321	0.00432	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000318	0.0026	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—CYP2A6—esophageal cancer	0.000317	0.00259	CbGpPWpGaD
Oseltamivir—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000315	0.00425	CcSEcCtD
Oseltamivir—Mental disorder—Capecitabine—esophageal cancer	0.000315	0.00424	CcSEcCtD
Oseltamivir—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000311	0.00418	CcSEcCtD
Oseltamivir—CES1—E2F transcription factor network—EP300—esophageal cancer	0.000309	0.00253	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CA1—esophageal cancer	0.000303	0.00248	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—SLC10A2—esophageal cancer	0.000303	0.00248	CbGpPWpGaD
Oseltamivir—Back pain—Capecitabine—esophageal cancer	0.000303	0.00408	CcSEcCtD
Oseltamivir—Pneumonia—Methotrexate—esophageal cancer	0.0003	0.00404	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000299	0.00403	CcSEcCtD
Oseltamivir—Infestation NOS—Methotrexate—esophageal cancer	0.000298	0.00401	CcSEcCtD
Oseltamivir—Infestation—Methotrexate—esophageal cancer	0.000298	0.00401	CcSEcCtD
Oseltamivir—NEU1—Metabolism—ADH1B—esophageal cancer	0.000298	0.00244	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—ACTB—esophageal cancer	0.000297	0.00243	CbGpPWpGaD
Oseltamivir—Pain—Cisplatin—esophageal cancer	0.000296	0.00399	CcSEcCtD
Oseltamivir—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000295	0.00398	CcSEcCtD
Oseltamivir—Conjunctivitis—Methotrexate—esophageal cancer	0.00029	0.0039	CcSEcCtD
Oseltamivir—Anaemia—Capecitabine—esophageal cancer	0.000289	0.00389	CcSEcCtD
Oseltamivir—Feeling abnormal—Cisplatin—esophageal cancer	0.000285	0.00384	CcSEcCtD
Oseltamivir—NEU1—Metabolism—TYMP—esophageal cancer	0.000285	0.00233	CbGpPWpGaD
Oseltamivir—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000282	0.0038	CcSEcCtD
Oseltamivir—Epistaxis—Methotrexate—esophageal cancer	0.000281	0.00379	CcSEcCtD
Oseltamivir—Vertigo—Capecitabine—esophageal cancer	0.000281	0.00379	CcSEcCtD
Oseltamivir—NEU1—Metabolism—CYP26A1—esophageal cancer	0.000277	0.00226	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CA2—esophageal cancer	0.000277	0.00226	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—CFL1—esophageal cancer	0.000274	0.00224	CbGpPWpGaD
Oseltamivir—Body temperature increased—Cisplatin—esophageal cancer	0.000274	0.00369	CcSEcCtD
Oseltamivir—Cough—Capecitabine—esophageal cancer	0.000273	0.00368	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000271	0.00221	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—ALOX15—esophageal cancer	0.00027	0.00221	CbGpPWpGaD
Oseltamivir—CES1—E2F transcription factor network—MYC—esophageal cancer	0.000269	0.0022	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—HSPA5—esophageal cancer	0.000268	0.00219	CbGpPWpGaD
Oseltamivir—Hepatitis—Methotrexate—esophageal cancer	0.000267	0.0036	CcSEcCtD
Oseltamivir—Arthralgia—Capecitabine—esophageal cancer	0.000266	0.00359	CcSEcCtD
Oseltamivir—Myalgia—Capecitabine—esophageal cancer	0.000266	0.00359	CcSEcCtD
Oseltamivir—Anxiety—Capecitabine—esophageal cancer	0.000265	0.00357	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000264	0.00356	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—CALR—esophageal cancer	0.00026	0.00213	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—GNG7—esophageal cancer	0.000258	0.00211	CbGpPWpGaD
Oseltamivir—Visual impairment—Methotrexate—esophageal cancer	0.000258	0.00347	CcSEcCtD
Oseltamivir—NEU1—Metabolism—TPI1—esophageal cancer	0.000257	0.0021	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—GSTO1—esophageal cancer	0.000257	0.0021	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PLCE1—esophageal cancer	0.000257	0.0021	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ADH7—esophageal cancer	0.000257	0.0021	CbGpPWpGaD
Oseltamivir—Confusional state—Capecitabine—esophageal cancer	0.000257	0.00347	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—GHRL—esophageal cancer	0.000256	0.00209	CbGpPWpGaD
Oseltamivir—Hypersensitivity—Cisplatin—esophageal cancer	0.000255	0.00344	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000254	0.00208	CbGpPWpGaD
Oseltamivir—Infection—Capecitabine—esophageal cancer	0.000254	0.00342	CcSEcCtD
Oseltamivir—Erythema multiforme—Methotrexate—esophageal cancer	0.000253	0.00341	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—FBXW7—esophageal cancer	0.000252	0.00206	CbGpPWpGaD
Oseltamivir—Nervous system disorder—Capecitabine—esophageal cancer	0.00025	0.00337	CcSEcCtD
Oseltamivir—Eye disorder—Methotrexate—esophageal cancer	0.00025	0.00337	CcSEcCtD
Oseltamivir—Thrombocytopenia—Capecitabine—esophageal cancer	0.00025	0.00337	CcSEcCtD
Oseltamivir—Asthenia—Cisplatin—esophageal cancer	0.000248	0.00335	CcSEcCtD
Oseltamivir—Cardiac disorder—Methotrexate—esophageal cancer	0.000248	0.00334	CcSEcCtD
Oseltamivir—Skin disorder—Capecitabine—esophageal cancer	0.000248	0.00334	CcSEcCtD
Oseltamivir—NEU1—Metabolism—ALDOB—esophageal cancer	0.000247	0.00202	CbGpPWpGaD
Oseltamivir—Immune system disorder—Methotrexate—esophageal cancer	0.000242	0.00325	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000241	0.00197	CbGpPWpGaD
Oseltamivir—Mediastinal disorder—Methotrexate—esophageal cancer	0.000241	0.00325	CcSEcCtD
Oseltamivir—NEU1—Metabolism—GAPDH—esophageal cancer	0.000238	0.00194	CbGpPWpGaD
Oseltamivir—Diarrhoea—Cisplatin—esophageal cancer	0.000237	0.00319	CcSEcCtD
Oseltamivir—NEU1—Metabolism—CRABP1—esophageal cancer	0.000235	0.00192	CbGpPWpGaD
Oseltamivir—Mental disorder—Methotrexate—esophageal cancer	0.000234	0.00316	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000233	0.00313	CcSEcCtD
Oseltamivir—Insomnia—Capecitabine—esophageal cancer	0.000231	0.00311	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000227	0.00185	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ADH1B—esophageal cancer	0.000226	0.00185	CbGpPWpGaD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—TP53—esophageal cancer	0.000225	0.00184	CbGpPWpGaD
Oseltamivir—Back pain—Methotrexate—esophageal cancer	0.000225	0.00303	CcSEcCtD
Oseltamivir—Dyspepsia—Capecitabine—esophageal cancer	0.000225	0.00303	CcSEcCtD
Oseltamivir—NEU1—Metabolism—GNG7—esophageal cancer	0.000224	0.00183	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—ATP1B2—esophageal cancer	0.000223	0.00183	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—TGFBR2—esophageal cancer	0.000222	0.00182	CbGpPWpGaD
Oseltamivir—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00022	0.00297	CcSEcCtD
Oseltamivir—ABCC4—Ectoderm Differentiation—SMAD4—esophageal cancer	0.00022	0.0018	CbGpPWpGaD
Oseltamivir—Vomiting—Cisplatin—esophageal cancer	0.00022	0.00297	CcSEcCtD
Oseltamivir—Fatigue—Capecitabine—esophageal cancer	0.00022	0.00296	CcSEcCtD
Oseltamivir—ABCC4—NRF2 pathway—HMOX1—esophageal cancer	0.000219	0.00179	CbGpPWpGaD
Oseltamivir—Rash—Cisplatin—esophageal cancer	0.000218	0.00294	CcSEcCtD
Oseltamivir—Pain—Capecitabine—esophageal cancer	0.000218	0.00294	CcSEcCtD
Oseltamivir—Dermatitis—Cisplatin—esophageal cancer	0.000218	0.00294	CcSEcCtD
Oseltamivir—NEU2—Metabolism—TYMP—esophageal cancer	0.000216	0.00176	CbGpPWpGaD
Oseltamivir—Anaemia—Methotrexate—esophageal cancer	0.000215	0.0029	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000215	0.00176	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000215	0.00175	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—HSPA5—esophageal cancer	0.000211	0.00172	CbGpPWpGaD
Oseltamivir—Feeling abnormal—Capecitabine—esophageal cancer	0.00021	0.00283	CcSEcCtD
Oseltamivir—NEU1—Metabolism—ALDH2—esophageal cancer	0.00021	0.00172	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CYP26A1—esophageal cancer	0.00021	0.00172	CbGpPWpGaD
Oseltamivir—Vertigo—Methotrexate—esophageal cancer	0.000209	0.00282	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000209	0.00281	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000206	0.00168	CbGpPWpGaD
Oseltamivir—Nausea—Cisplatin—esophageal cancer	0.000206	0.00277	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000205	0.00168	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ALOX15—esophageal cancer	0.000205	0.00167	CbGpPWpGaD
Oseltamivir—Cough—Methotrexate—esophageal cancer	0.000203	0.00274	CcSEcCtD
Oseltamivir—Urticaria—Capecitabine—esophageal cancer	0.000203	0.00273	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—DOCK2—esophageal cancer	0.000202	0.00165	CbGpPWpGaD
Oseltamivir—Abdominal pain—Capecitabine—esophageal cancer	0.000202	0.00272	CcSEcCtD
Oseltamivir—Body temperature increased—Capecitabine—esophageal cancer	0.000202	0.00272	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000202	0.00165	CbGpPWpGaD
Oseltamivir—Convulsion—Methotrexate—esophageal cancer	0.000202	0.00272	CcSEcCtD
Oseltamivir—NEU1—Metabolism—GSTT1—esophageal cancer	0.0002	0.00163	CbGpPWpGaD
Oseltamivir—Myalgia—Methotrexate—esophageal cancer	0.000198	0.00267	CcSEcCtD
Oseltamivir—Arthralgia—Methotrexate—esophageal cancer	0.000198	0.00267	CcSEcCtD
Oseltamivir—NEU1—Metabolism—CYP2A6—esophageal cancer	0.000197	0.00161	CbGpPWpGaD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000197	0.00265	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000197	0.00161	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000197	0.00161	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000197	0.00161	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—TPI1—esophageal cancer	0.000195	0.0016	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GSTO1—esophageal cancer	0.000195	0.0016	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000193	0.00158	CbGpPWpGaD
Oseltamivir—Confusional state—Methotrexate—esophageal cancer	0.000192	0.00258	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000191	0.00156	CbGpPWpGaD
Oseltamivir—Anaphylactic shock—Methotrexate—esophageal cancer	0.00019	0.00256	CcSEcCtD
Oseltamivir—Infection—Methotrexate—esophageal cancer	0.000189	0.00254	CcSEcCtD
Oseltamivir—Hypersensitivity—Capecitabine—esophageal cancer	0.000188	0.00253	CcSEcCtD
Oseltamivir—NEU1—Metabolism—ENO1—esophageal cancer	0.000187	0.00153	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PTGS1—esophageal cancer	0.000187	0.00153	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ALDOB—esophageal cancer	0.000187	0.00153	CbGpPWpGaD
Oseltamivir—Nervous system disorder—Methotrexate—esophageal cancer	0.000186	0.00251	CcSEcCtD
Oseltamivir—Thrombocytopenia—Methotrexate—esophageal cancer	0.000186	0.00251	CcSEcCtD
Oseltamivir—Skin disorder—Methotrexate—esophageal cancer	0.000185	0.00249	CcSEcCtD
Oseltamivir—NEU1—Metabolism—PSME2—esophageal cancer	0.000184	0.00151	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PSME1—esophageal cancer	0.000184	0.00151	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000183	0.0015	CbGpPWpGaD
Oseltamivir—Asthenia—Capecitabine—esophageal cancer	0.000183	0.00247	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000182	0.00149	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GAPDH—esophageal cancer	0.00018	0.00147	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CRABP1—esophageal cancer	0.000178	0.00146	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000175	0.00143	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000175	0.00143	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000175	0.00143	CbGpPWpGaD
Oseltamivir—Diarrhoea—Capecitabine—esophageal cancer	0.000175	0.00235	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—PFN1—esophageal cancer	0.000174	0.00143	CbGpPWpGaD
Oseltamivir—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000173	0.00233	CcSEcCtD
Oseltamivir—Insomnia—Methotrexate—esophageal cancer	0.000172	0.00231	CcSEcCtD
Oseltamivir—NEU2—Metabolism—GNG7—esophageal cancer	0.00017	0.00139	CbGpPWpGaD
Oseltamivir—Dizziness—Capecitabine—esophageal cancer	0.000169	0.00227	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000168	0.00137	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000168	0.00137	CbGpPWpGaD
Oseltamivir—Dyspepsia—Methotrexate—esophageal cancer	0.000167	0.00225	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000164	0.00221	CcSEcCtD
Oseltamivir—Fatigue—Methotrexate—esophageal cancer	0.000164	0.00221	CcSEcCtD
Oseltamivir—Pain—Methotrexate—esophageal cancer	0.000162	0.00219	CcSEcCtD
Oseltamivir—Vomiting—Capecitabine—esophageal cancer	0.000162	0.00219	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000161	0.00132	CbGpPWpGaD
Oseltamivir—Rash—Capecitabine—esophageal cancer	0.000161	0.00217	CcSEcCtD
Oseltamivir—Dermatitis—Capecitabine—esophageal cancer	0.000161	0.00217	CcSEcCtD
Oseltamivir—Headache—Capecitabine—esophageal cancer	0.00016	0.00215	CcSEcCtD
Oseltamivir—NEU1—Metabolism—CYP1B1—esophageal cancer	0.000159	0.0013	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ALDH2—esophageal cancer	0.000159	0.0013	CbGpPWpGaD
Oseltamivir—Feeling abnormal—Methotrexate—esophageal cancer	0.000157	0.00211	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000155	0.00209	CcSEcCtD
Oseltamivir—Nausea—Capecitabine—esophageal cancer	0.000152	0.00204	CcSEcCtD
Oseltamivir—NEU2—Metabolism—GSTT1—esophageal cancer	0.000151	0.00124	CbGpPWpGaD
Oseltamivir—Urticaria—Methotrexate—esophageal cancer	0.000151	0.00203	CcSEcCtD
Oseltamivir—Body temperature increased—Methotrexate—esophageal cancer	0.00015	0.00202	CcSEcCtD
Oseltamivir—Abdominal pain—Methotrexate—esophageal cancer	0.00015	0.00202	CcSEcCtD
Oseltamivir—NEU1—Metabolism—CYP19A1—esophageal cancer	0.00015	0.00122	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CYP2A6—esophageal cancer	0.00015	0.00122	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000149	0.00122	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000149	0.00122	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ENO1—esophageal cancer	0.000142	0.00116	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PTGS1—esophageal cancer	0.000142	0.00116	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—CFL1—esophageal cancer	0.000141	0.00116	CbGpPWpGaD
Oseltamivir—Hypersensitivity—Methotrexate—esophageal cancer	0.00014	0.00189	CcSEcCtD
Oseltamivir—NEU2—Metabolism—PSME1—esophageal cancer	0.00014	0.00114	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PSME2—esophageal cancer	0.00014	0.00114	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—HMOX1—esophageal cancer	0.000136	0.00112	CbGpPWpGaD
Oseltamivir—Asthenia—Methotrexate—esophageal cancer	0.000136	0.00184	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000135	0.00111	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.000134	0.00109	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—GNG7—esophageal cancer	0.000133	0.00109	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000133	0.00108	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—ABCB1—esophageal cancer	0.000131	0.00107	CbGpPWpGaD
Oseltamivir—Diarrhoea—Methotrexate—esophageal cancer	0.00013	0.00175	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000127	0.00104	CbGpPWpGaD
Oseltamivir—Dizziness—Methotrexate—esophageal cancer	0.000126	0.00169	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000122	0.000997	CbGpPWpGaD
Oseltamivir—Vomiting—Methotrexate—esophageal cancer	0.000121	0.00163	CcSEcCtD
Oseltamivir—NEU2—Metabolism—CYP1B1—esophageal cancer	0.000121	0.000985	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.00012	0.000983	CbGpPWpGaD
Oseltamivir—Rash—Methotrexate—esophageal cancer	0.00012	0.00161	CcSEcCtD
Oseltamivir—Dermatitis—Methotrexate—esophageal cancer	0.00012	0.00161	CcSEcCtD
Oseltamivir—Headache—Methotrexate—esophageal cancer	0.000119	0.0016	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000115	0.000943	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CYP19A1—esophageal cancer	0.000113	0.000927	CbGpPWpGaD
Oseltamivir—Nausea—Methotrexate—esophageal cancer	0.000113	0.00152	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—HSPA5—esophageal cancer	0.000109	0.000888	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—HMOX1—esophageal cancer	0.000103	0.000845	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.000101	0.000829	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ABCB1—esophageal cancer	9.93e-05	0.000811	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.9e-05	0.00081	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—CREBBP—esophageal cancer	8.75e-05	0.000716	CbGpPWpGaD
Oseltamivir—ABCC4—Ectoderm Differentiation—MYC—esophageal cancer	8.74e-05	0.000714	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	8.24e-05	0.000674	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—ABL1—esophageal cancer	8.05e-05	0.000658	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	7.91e-05	0.000647	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—NOS3—esophageal cancer	7.84e-05	0.000641	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.51e-05	0.000614	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—HMOX1—esophageal cancer	7.33e-05	0.000599	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PTGS2—esophageal cancer	7.17e-05	0.000586	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ABCB1—esophageal cancer	7.04e-05	0.000575	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—HMOX1—esophageal cancer	7.03e-05	0.000574	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ABCB1—esophageal cancer	6.75e-05	0.000551	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CREBBP—esophageal cancer	6.63e-05	0.000542	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—EP300—esophageal cancer	5.96e-05	0.000487	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—NOS3—esophageal cancer	5.94e-05	0.000486	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—NOS2—esophageal cancer	5.8e-05	0.000474	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PTGS2—esophageal cancer	5.43e-05	0.000444	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	5.29e-05	0.000432	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—CREBBP—esophageal cancer	5.21e-05	0.000426	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	5.09e-05	0.000416	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.7e-05	0.000384	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—NOS3—esophageal cancer	4.66e-05	0.000381	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—EP300—esophageal cancer	4.52e-05	0.000369	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.51e-05	0.000369	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PIK3CA—esophageal cancer	4.41e-05	0.000361	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—EP300—esophageal cancer	3.55e-05	0.00029	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PIK3CA—esophageal cancer	3.34e-05	0.000273	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PIK3CA—esophageal cancer	2.62e-05	0.000214	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—TP53—esophageal cancer	2.54e-05	0.000207	CbGpPWpGaD
